Developing innovative vaccines to protect against influenza
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center
This study is looking for ways to make better flu vaccines that can protect you for a longer time and against different types of the flu, and you might have a chance to join in and help test these new vaccines!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11042031 on NIH RePORTER |
What this research studies
This research focuses on creating and testing new influenza vaccine candidates that can provide long-lasting and broad protection against various strains of the flu virus. The approach includes analyzing immune responses to inform vaccine design, conducting laboratory tests to assess how well these vaccines work, and developing necessary tools for testing. Clinical studies will also be conducted to evaluate the effectiveness of these vaccines in real-world settings. Patients may have the opportunity to participate in trials that could lead to more effective flu vaccines.
Who could benefit from this research
Good fit: Ideal candidates for participation would include individuals at high risk for influenza complications, such as the elderly, young children, and those with underlying health conditions.
Not a fit: Patients who are not at risk for influenza or those who have already received a flu vaccine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a universal influenza vaccine that offers better protection against multiple strains of the virus.
How similar studies have performed: Other research has shown promise in developing innovative vaccine approaches, but this specific initiative aims to create a novel universal influenza vaccine, making it a potentially groundbreaking effort.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Moody, Tony — Duke University
- Study coordinator: Moody, Tony
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.